Approval Of Drug For Friedreich’s Ataxia Could Open Door For Other Researchers Of Rare Illnesses
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
The independent source for health policy research, polling, and news.
8,841-8,860 of 113,016 results
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
The company said the changes take effect immediately and include two of its most popular drugs, Humalog and Humulin. The move comes on the heels of President Joe Biden's State of the Union speech last month that pressed for the $35 monthly cap to be expanded beyond Medicare to include every diabetes patient.
House committees in both states moved bills forward that would provide additional Medicaid coverage to qualifying people for 12 months after giving birth. The Hill reports on efforts in 28 states to offer additional postpartum benefits.
The covid vaccine maker "raised doubts" about its business future, Reuters reports, even as it works toward a fall vaccination campaign. Meanwhile, news outlets report on the increasing spread of omicron covid, how structural brain changes link to long covid symptoms like fatigue, and more.
News outlets report on the vote by an FDA panel, which assessed Pfizer's data on the safety and effectiveness of Pfizer's vaccine for respiratory syncytial virus. The panel concluded it was safe for adults 60 and over. The FDA is set to make a formal decision on the drug soon.
The action allows for the detainment of shipments of the veterinary tranquilizer and the ingredients used to make it, CBS News reported. Xylazine, also known as "tranq" or "zombie drug" because it causes “patches of dead and rotting tissue," has exacerbated the nation's opioid crisis and has been found in samples from 32 states, The Washington Post says.
In a speech Tuesday, President Joe Biden pressured Republicans to release their plans to cut government spending, which are expected to target Medicaid and the Affordable Care Act. And in another preview of the 2024 presidential race, Donald Trump is warning his party against touching Medicare.
It's estimated that tens of millions of low-income Americans on SNAP will lose about $95 a month for groceries, at a time when food prices are already high. States, food banks, and assistance groups have been scrambling to prepare for the onslaught of people who could struggle with hunger, especially kids, older Americans, and those with chronic illnesses.
Axios reports that Sens. Ron Wyden (D-Ore.) and Mazie Hirono (D-Hawaii) and Rep. Sara Jacobs (D-Calif.) expressed concern in a letter Monday evening that FBI and Department of Homeland Security resources could be used to help undermine access to reproductive care.
Today's early morning highlights from the major news organizations.
Opinion writers delve into these public health topics.
Editorial writers discuss the latest on covid's origin, covid boosters and masking.
The Food and Drug Administration has reportedly linked the rare neurological condition to Pfizer's respiratory syncytial virus vaccine — in the Phase 3 trial, two people in their 60s, out of roughly 20,000 total recipients, were diagnosed, though both are recovering. Also: risks of fitness trackers, stem cell treatments, and more.
Fox News says Florida-based The Wellness Company, a virtual provider of "health care, supplements and wellness services" will offer free medical care for those affected by the toxic train derailment. A House committee will probe the EPA's response to the incident, Reuters says.
New Hampshire's use of hospital emergency departments for beds for mental health patients amounts to "illegal seizure" of hospital property, New Hampshire Public Radio reports. Meanwhile, North Carolina Health News covers impacts of mental health worker shortages.
Stat reports that Billy Dunn, who presided over the controversial approval of the Alzheimer's drug Aduhelm, will retire to pursue other opportunities. Meanwhile, CBS News says the FDA has recently approved the first drug that can slow the vision-loss illness geographic atrophy.
New estimates from Georgetown University Health Policy Institute show millions of children and teens are at risk of losing coverage at the end of the public health emergency. Separately, Centene Corp. expects to lose millions of Medicaid customers, the St. Louis Post-Dispatch says.
The Health and Human Services agency announced that over 51,000 complaints were filed against health agencies last year, and AP reports that complaints have grown 69% over five years. A backlog of investigations has resulted. Separately, surprise billing lawsuits are said to be slowing payments.
At issue is a 2019 law that makes it illegal to discriminate against workers because of their "reproductive health decision making." A U.S. appeals court said the law violates an anti-abortion crisis pregnancy center's constitutional rights by forcing it to employ people who go against its message, Reuters reported.
The findings come from a preliminary study and health experts offered varying opinions to Stat News about how consumers should react to the potential risk. Some said people at heart attack risk should avoid the sugar substitute outright, while others worry about the dangers of other sugar-heavy products.
© 2026 KFF